Influence of drug incorporation, temperature and storage time on the pH, textural and rheological properties of different poloxamer hydrogels

Current Drug Delivery

Volumn 10, Issue 6, 2013, Pages 753-764

  Almeida, Hugo ^a   Amaral, Maria Helena ^a   Lobão, Paulo ^a   Sousa Lobo, José Manuel ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Hydrocortisone; Hydrogels; Ibuprofen; Poloxamers; Texture; Viscosity

Indexed keywords

HYDROCORTISONE; IBUPROFEN; POLOXAMER; POLYMER;

ADHESION; ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; FLOW KINETICS; HYDRATION; HYDROGEL; HYDROPHILICITY; HYDROPHOBICITY; PH; PRIORITY JOURNAL; STORAGE; SUSTAINED DRUG RELEASE; TEMPERATURE SENSITIVITY; VISCOSITY;

ADHESIVENESS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STORAGE; HYDROCORTISONE; HYDROGELS; HYDROGEN-ION CONCENTRATION; IBUPROFEN; POLOXAMER; POLYETHYLENES; POLYPROPYLENES; RHEOLOGY; TEMPERATURE; TIME FACTORS; VISCOSITY;

EID: 84889072376     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/15672018113109990056     Document Type: Article

References (67)

1. Nirmal, H.B.; Bakliwal, S.R.; Pawar, S.P. In-Situ gel: New trends in Controlled and Sustained Drug Delivery System. Int. J. Pharm. Tech. Res., 2010, 2(2), 1398-1408.
2. Abdel-Mottaleb, M.M.A.; Mortada, N.D.; Elshamy, A.A.; Awad, G.A.S. Preparation and evaluation of Fluconazole Gels. Egypt J. Biomed. Sci., 2007, 23(1), 266-286.
3. Li, X.; Zhang, Z.; Chen, H. Development and evaluation of fast forming nano-composite hydrogel for ocular delivery of diclofenac. Int. J. Pharm., 2013, 448(1), 96-100
4. Vodithala, S.; Khatry, S.; Shastri, N.; Sadanandam, M. Development and evaluation of thermoreversible ocular gels of ketorolac tromethamine. Int. J. Biopharm., 2010, 1(1), 39-45.
5. Almeida, H.; Amaral, M.H.; Lobão, P.; Sousa Lobo, J.M. Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): Main features and their applications in topical and transdermal administration of drugs. J. Pharm. Pharm. Sci., 2012, 15(4), 592-605.
6. Kurkuri, M.D.; Kulkarni, A.R.; Aminabhavi, T.M. Rheological investigations on the dispersions of sodium alginate and guar gum mixtures at different temperatures. Polym. Plast. Technol. Eng., 2002, 41(3), 469-488.
7. Dumortier, G.; Grossiord, J.L.; Agnely, F.; Chaumeil, J.C. A review of polaxamer 407 pharmaceutical and pharmacological characteristics. Pharm. Res., 2006, 23(12), 2709-2728.
8. Escobar-Chávez, J.J.; López-Cervantes, M.; Naik, A.; Kalia, Y. N; Quintanar-Guerrero, D.; Ganem-Quintanar, A. Applications of thermo-reversible Pluronic F-127 gels in Pharmaceutical formulations. J. Pharm. Pharm. Sci., 2006, 9(3), 339-358.
9. Edsman, K.; Carlfors, J.; Petersson, R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur. J. Pharm. Sci., 1998, 6(2), 105-112.
10. Gil, E.S.; Hudson, S.M. Stimuli-responsive polymers and their bioconjugates. Prog. Polym. Sci., 2004, 29(12), 1173-1222.
11. Rokhade, A.P.; Shelke, N.B.; Patil, S.A.; Aminabhavi, T.M. Novel hydrogel microspheres of chitosan and pluronic F-127 for controlled release of 5-fluorouracil. J. Microencapsul., 2007, 24(3), 274-288.
12. Veyries, M.L.; Couarraze, G.; Geiger, S.; Agnely, F.; Massias, L.; Kunzli, B.; Faurisson, F.; Rouveix, B. Controlled release of vancomycin from Poloxamer 407 gels. Int. J. Pharm., 1999, 192(2), 183-193.
13. Cabana, A.; Ait-Kadi, A.; Juhász, J. Study of the gelation process of polyethylene oxidepolypropylene oxide - polyethylene oxide copolymer (poloxamer 407) aqueous solutions. J. Colloid. Interface Sci., 1997, 190(2), 307-312.
14. Lin, H.R.; Sung, K.C. Carbopol/Pluronic phase change solutions for ophthalmic drug delivery. J. Control. Release, 2000, 69(3), 379-388.
15. Chang, J.Y.; Oh, Y.K.; Kong, H.S.; Kim, E.J.; Jang, D.D.; Nam, K.T.; Kim, C.K. Prolonged antifungal effects of clotrimazolecontaining mucoadhesive thermosensitive gels on vaginitis. J. Control. Release, 2002, 82(1), 39-50.
16. Chang, J.Y.; Oh, Y.K.; Choi, H.G.; Kim, Y.B.; Kim, C.K. Rheological evaluation of thermosensitive and mucoadhesive vaginals gels in physiological conditions. Int. J. Pharm., 2002, 241(1), 155-163.
17. Ricci, E.J.; Lunardi, L.O.; Nanclares, D.M.A.; Marchetti, J.M. Sustained release of lidocaine from Poloxamer 407 gels. Int. J. Pharm., 2005, 288(2), 235-244.
18. Li, G.; Li, M. Preparation and evaluation of ophthalmic thermosensitive in situ gels of penciclovir. J. Chinese Pharm. Sci., 2007, 16(2), 90-95.
19. Qi, H.; Chen, W.; Huang, C.; Li L.; Chen, C.; Li, W.; Wu, C. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int. J. Pharm., 2007, 337(1-2), 178-187.
20. Fogueri, L.R.;Singh, S. Smart Polymers for Controlled Delivery of Proteins and Peptides: A Review of Patents. Recent Pat. Drug Deliv. Formul., 2009, 3(1), 40-48.
21. Asasutjarit, R.; Thanasanchokpibull S.; Fuongfuchat A.; Veeranondha S. Optimization and Evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gel. Int. J. Pharm., 2011, 411(1-2), 128-135.
22. Shelke, N.B.; Rokhade, A.P.; Aminabhavi, T.M. Preparation and Evaluation of Novel Blend Microspheres of Poly(lactic-coglycolic) acid and Pluronic F68/127 for Controlled Release of Repaglinide. J. Appl. Polym. Sci., 2010, 160(1), 366-372.
23. Yuan, Y.; Ying, C.; Li, Z.; Hui-ping, G.; Yi-Sha, G.; Bo, Z.; Xia, H.; Ling, Z.; Xiao-hui, W.; Li, C. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide. Int. J. Pharm., 2012, 430(1-2), 114-119.
24. Shelke, N.B.; Aminabhavi, T.M. Synthesis and characterization of novel poly (sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine. Int. J. Pharm., 2007, 345(1-2), 51-58.
25. Chen, X.; Zhi, F.; Jia, X.; Zhang, X.; Ambardekar, R.; Men, Z.; Paradkar, A.R.; Hu, Y.; Yang, Y. Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel. J. Pharm. Pharmacol., 2013, 65(6), 807-816.
26. Pluronic® Block Copolymer NF Grades. Technical Bulletin. BASF Corporation. http://worldaccount.basf.com/wa/NAFTA/Catalog/ ChemicalsNAFTA/doc4/BASF/PRD/30089190/.pdf?title=&asset_ type=pi/pdf&language=EN&urn=urn:documentum:eCommerce_so l_EU:09007bb28001f733.pdf. (Accessed January 13, 2013).
27. Bochot, A.; Fattal, E.; Grossiord, J.L.; Puisieux, F.; Couvreur, P. Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel. Int. J. Pharm., 1998, 162(1-2), 119-127.
28. El-Kamel, A.H. In vitro and in vivo evaluation of Pluronic F127- based ocular delivery system for timolol maleate. Int. J. Pharm., 2002, 241(1), 47-55.
29. Lee, S.H.; Lee, J.E.; Baek, W.Y.; Lim, J.O. Regional delivery of vancomycin using pluronic F-127 to inhibit methicillin resistant Staphylococcus aureus (MRSA) growth in chronic otitis media in vitro and in vivo. J. Control. Release, 2004, 96(1), 1-7.
30. Wagh, V.D.; Deshmukh, K.H.; Wagh, K.V. Formulation and Evaluation of in situ Gel Drug Delivery System of Sesbania grandiflora Flower Extract for the Treatment of Bacterial Conjunctivitis. J. Pharm. Sci. Res., 2012, 4(8), 1880-1884.
31. Gratieri, T.; Gelfuso, G.M.; Rocha, E.M.; Sarmento, V.H.; Freitas, O.; Lopez, R.F.V. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur. J. Pharm. Biopharm., 2010, 75(2), 186-193.
32. Ye, F.; Yaghmur, A.; Jensen, H.; Larsen, S.W.; Larsen, C.; Ostergaard J. Real-time UV imaging of drug diffusion and release from Pluronic F127 hydrogels. Eur. J. Pharm. Sci., 2011, 43(4), 236-243.
33. Pandit, N.K.; Kisaka, J. Loss of gelation ability of Pluronic® F127 in the presence of some salts. Int. J. Pharm., 1996, 145(1-2), 129-136.
34. Pandit, N.K.; Wang, D. Salts effects on the diffusion and release rate of propranolol from poloxamer 407 gels. Int. J. Pharm., 1998, 167(1-2), 183-189.
35. Shin, S.C.; Cho, C.W.; Oh, I.J. Effects of non ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins. Int. J. Pharm., 2001, 222(2), 199-203.
36. Shin, S.; Cho, C.; Oh, I. Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats. Int. J. Pharm., 2000, 193(2), 213-218.
37. DiBiase, M.D.; Rhodes, C.T. Investigations of epidermal growth factor in semisolid formulations. Pharm. Acta. Helv., 1991, 66(5-6), 165-169.
38. Shin, S.C.; Kim, J-Y. Enhanced permeation of triamcinolone acetonide through the bucal mucosa. Eur. J. Pharm. Biopharm., 2000, 50(2), 217-220.
39. Miyazaki, S.; Takeuchi, S.; Yokouchi, C.; Takada, M. Pluronic F- 127 gels as a vehicle for topical administration to anticancer agents. Chem. Pharm. Bull., 1984, 32(10), 4205-4208.
40. Wang, Y.Y.; Hong, C.T.; Chiu, W.T.; Fang, J.Y. In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels. Int. J. Pharm., 2001, 224(1-2), 89-104.
41. Shawesh, A.; Kallioinen, S.; Hellen, L.; Yliruusi, J. Pluronic F-127 gels as a vehicle for topical formulations of indomethacin and rheological behaviour of these formulations. Pharmazie, 2002, 57(3), 186-190.
42. Shin, S.C.; Lee, J.W.; Yang, K.H.; Lee, C.H. Preparation and evaluation of bioadhesive benzocaine gels for enhanced local anesthetic effects. Int. J. Pharm., 2003, 260(1), 77-81.
43. Pandey, M.S.; Belgamwar, V.S.; Surana, S.J. Topical Delivery of Flurbiprofen from Pluronic Lecithin Organogel. Indian J. Pharm. Sci., 2009, 71(1), 87-90.
44. Abd-Allah, F.I.; Dawaba, H.M.; Ahmed, A.M. Preparation, characterization, and stability studies of piroxicam-loaded microemulsions in topical formulations. Drug Discov. Ther., 2010, 4(4), 267-275.
45. Barichello, J.M.; Morishita, M.; Takayama, K.; Nagai, T. Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats. Int. J. Pharm., 1999, 184(2), 189-199.
46. Chaudhary, H.R.; Brocks, D.R. The Single Dose Poloxamer 407 Model of Hyperlipidemia; Systemic Effects on Lipids Assessed Using Pharmacokinetic Methods, and its Effects on Adipokines. J. Pharm. Pharm. Sci., 2013, 16(1), 65-73.
47. Jain, N.K.; Shah, B.K.; Taneja, L.N. Nasal absorption of metoprolol tartrate, Indian J. Pharm. Sci., 1991, 53(1), 16-19.
48. Miyazaki, S.; Yokouchi, C.; Nakamura, T.; Hashiguchi, N.; Hou, W-M.; Takada, M. Pluronic F-127 gels as a novel vehicle for rectal 764administration of Indomethacin. Chem. Pharm. Bull., 1986, 34(4), 1801-1808.
49. Higashiyama, M.; Inada, K.; Ohtori, A.; Tojo, K. Improvement of the ocular bioavailability of timolol by sorbic acid. Int. J. Pharm., 2004, 272(1-2), 91-98.
50. Shin, S.C.; Cho C.W. Enhanced transdermal delivery of pranoprofen from the bioadhesive gels. Arch. Pharm. Res., 2006, 29(10), 928-933.
51. Stamatialis, D.F.; Rolevink, H.H.M.; Koops, G.H. Transdermal timolol delivery from a Pluronic gel. J. Control. Release, 2006, 116(2), e53-e55.
52. Chen, C.C.; Fang, C.L.; Al-Suwayeh, S.A.; Leu, Y.L.; Fang, J.Y. Transdermal delivery of selegiline from alginate-Pluronic composite thermogels. Int. J. Pharm., 2011, 415(1-2), 119-128.
53. Portolés, M.; Austin, F.; Nos-Barbera, S.; Paterson, C.; Refojo, M.F. Effect of poloxamer 407 on the adherence of Pseudomonas aeruginosa to corneal epithelial cells. Cornea, 1995, 14(1), 56-61.
54. Oswald, W.; Guimarães S. Terapêutica medicamentosa e suas bases farmacológicas, 4th ed.; Porto Editora: Porto, 2001.
55. Brunton, L.L.; Lazo, J.S.; Parker, K.L. Goodman & Gilman's: as bases farmacológicas da terapêutica, 11th ed.; McGraw-Hill: Columbus, 2007.
56. Loisa, P.; Parviainen, I.; Tenhunen, J.; Hovilehto, S.; Ruokonen, E. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial. Crit. Care, 2007, 11(1), R21.
57. Portuguese Pharmacopeia 9.0. Lisboa: Infarmed - Ministério da Saúde; 2009.
58. Almeida, I.F.; Bahia, M.F. Evaluation of the physical stability of two oleogels. Int. J. Pharm., 2006, 327(1), 73-77.
59. Neves, J.; Silva, M.V.; Gonçalves, M.P.; Amaral, M.H.; Bahia, M.F. Rheological Properties of Vaginal Hydrophilic Polymer Gels. Curr. Drug. Deliv., 2009, 6(1), 83-92.
60. Lee, C.H.; Moturi, V.; Lee, Y. Thixotropic property in pharmaceutical formulations. J. Control. Release, 2009, 136(2), 88-98.
61. Barnes, H.A. Thixotropy - a review. J. Non-Newton. Fluid Mech., 1997, 70(1-2), 1-33.
62. Rao, M.A. Rheology of Fluid and Semisolid Foods: Principles and Applications, 2nd ed.; Springer: Berlin, 2007.
63. Connors, K.A.; Amidon, G.L.; Kennon, L. Chemical stability of pharmaceuticals: a handbook for pharmacists, 1st ed.; Wiley: New York; 1979.
64. Gupta, V.D. Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents. Int. J. Pharm. Compound., 2007, 11(3), 259-261.
65. Sharma, P.K.; Bhatia, S.R. Effect of antiinflammatories on pluronic F127: micellar assembly, gelation and partitioning. Int. J. Pharm., 2004, 278(2), 361-377.
66. Lenaerts, V.; Triqueneux, C.; Quarton, M.; Rieg-Falson, F.; Couvreur, P. Temperature-dependent rheological behavior of Pluronic F-127. Int. J. Pharm., 1987, 39(1-2), 121-127.
67. Jeong, B.; Gutowska, A. Lessons from Nature: stimuli-responsive polymers and their biomedical applications. Trends Biotechnol., 2002, 20(7), 305-310.